Table 6.
Patient-based coverage of blood culture pathogens
| Risc factor | CTX | TZP | CP | |||||
|---|---|---|---|---|---|---|---|---|
| n | p-value | p-value | p-value | |||||
| Time of bile collection from admission | ≤ 48 h | 21 | 71.4% | 0.062 | 81.0% | 0.044 | 95.2% | 0.101 |
| > 48 h | 23 | 43.5% | 52.2% | 78.3% | ||||
| ICU† | no | 29 | 69.0% | 0.024 | 75.9% | 0.053 | 89.7% | 0.376 |
| yes | 15 | 33.3% | 46.7% | 80.0% | ||||
| Indwelling biliary tract drainage | no | 22 | 68.2% | 0.128 | 81.8% | 0.026 | 90.9% | 0.380 |
| yes | 22 | 45.5% | 50.0% | 81.8% | ||||
| Any of the above risk factors | no | 9 | 77.8% | 0.155 | 100.0% | 0.016 | 100.0% | 0.181 |
| yes | 35 | 51.4% | 57.1% | 82.9% | ||||
Percentages indicate the proportion of patients for whom all blood culture pathogens would have been covered by the respective antibiotic
CTX cefotaxime, TZP piperacillin/tazobactam, CP carbapenem
†ICU, treatment on ICU before or during bile sampling